{"id":"W2415670168","doi":"10.1016/j.vascn.2016.06.002","title":"The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress","year":2016,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Proarrhythmia; hERG; Drug development; Risk analysis (engineering); Pharmacology; Medicine; Drug; Potassium channel; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05955164014024995,"score_gpt":0.4138895920665002,"score_spread":0.3543379519262502,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}